Ptc Therapeutics (PTCT) Other Non-Current Liabilities (2012 - 2026)

Ptc Therapeutics' Other Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $13.7 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $13.7 million (changed N/A YoY), while the FY2025 annual figure was $13.7 million, up 1613.0% from the prior year.
• Other Non-Current Liabilities was $13.7 million for Q1 2026 at Ptc Therapeutics, roughly flat from $13.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $228.2 million in Q1 2022 to a low of $77000.0 in Q3 2024.
• Historically, Other Non-Current Liabilities has averaged $32.0 million across 5 years, with a median of $3.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities tumbled 99.94% in 2023, then jumped 25573.76% in 2024.
• A 5-year view of Other Non-Current Liabilities shows it stood at $2.6 million in 2022, then slumped by 94.66% to $141000.0 in 2023, then soared by 467.38% to $800000.0 in 2024, then jumped by 1613.0% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $13.7 million (Q1 2026), $13.7 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.